机译:Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Trial
Department of Urology CHU Pontchaillou Rennes University;
Department of Medical Oncology Centre Antoine Lacassagne Université C?te d'Azur;